Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Antonia Zonno"'
Autor:
Francesca Vignani, Rosa Tambaro, Ugo De Giorgi, Patrizia Giannatempo, Davide Bimbatti, Claudia Carella, Marco Stellato, Francesco Atzori, Michele Aieta, Cristina Masini, Alketa Hamzaj, Paola Ermacora, Antonello Veccia, Giuseppa Scandurra, Teresa Gamba, Gianluca Ignazzi, Sandro Pignata, Marilena Di Napoli, Cristian Lolli, Giuseppe Procopio, Francesco Pierantoni, Antonia Zonno, Daniele Santini, Massimo Di Maio
Platinum-based chemotherapy (PBCT) is the standard first-line treatment for advanced urothelial carcinoma (UC). Potential cross-sensitivity can be hypothesized between platinum drugs and poly-ADP ribose-polymerase (PARP) inhibitors.To compare mainten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84477958d8d2a561ad2f8807b97a8a96
https://hdl.handle.net/2318/1887415
https://hdl.handle.net/2318/1887415
Autor:
Daniela Petriella, Gabriella Del Bene, Rosamaria Pinto, Simona De Summa, Annamaria Catino, Pamela Pizzutilo, Francesco Alfredo Zito, Rosanna Lacalamita, Antonia Zonno, Stefania Tommasi, Michele Montrone, Maria Antonietta Botticella
Publikováno v:
Cancers
Cancers, Vol 11, Iss 8, p 1145 (2019)
Volume 11
Issue 8
Cancers, Vol 11, Iss 8, p 1145 (2019)
Volume 11
Issue 8
Non-small-cell lung cancer, histologically classified into adenocarcinoma (AD) and squamous cell carcinoma, is one of the most deadly malignancies worldwide. Lung AD (LUAD) could benefit of a plethora of target therapies and, in the last few years, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::874ed0edfe5c1865761381ab6c6f60a5
http://europepmc.org/articles/PMC6721568
http://europepmc.org/articles/PMC6721568
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
G. Mansueto, Giulia Vita, Oreste Villani, Antonia Zonno, Gabriella Bianchino, Roberto Guariglia, Pellegrino Musto, Fiorella D'Auria, Vitina Grieco, Luigina Di Giovannantonio
Publikováno v:
Clinical Therapeutics. 32:1911-1916
Background: CD20 antigen down-modulation by anti-CD20 rituximab treatment is a well-recognized phenomenon in patients with non-Hodgkin's lymphoma. However, few data are currently available on this topic in other lymphoproliferative disorders, in part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c008968f74929fe5106acdf0809f0c38
https://doi.org/10.1016/j.clinthera.2010.10.005
https://doi.org/10.1016/j.clinthera.2010.10.005
Autor:
Fiorella D'Auria, Vitina Grieco, Rosa Lerose, Antonia Zonno, Roberto Guariglia, Giuseppe Pietrantuono, Antonietta Falcone, Grazia Sanpaolo, G. Mansueto, Maria Carmen Martorelli, Gabriella Bianchino, Oreste Villani, Anna Sparano, Pellegrino Musto
Publikováno v:
Leukemia Research. 34:981-985
This was a retrospective, comparative study focused on the extended follow-up of 192 transfusion-dependent patients with myelodysplastic syndromes treated (n. 83) or not treated (n. 109) with recombinant erythropoietin alpha (r-EPO) as single agent d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a4682383c8a0653ad77193eafa9b2a0
https://doi.org/10.1016/j.leukres.2009.10.022
https://doi.org/10.1016/j.leukres.2009.10.022
Autor:
Roberta Faccio, Silvana Capalbo, Silvia Colucci, Rita Rizzi, Maria Grano, Vincenzo Liso, Antonia Zonno, Davide Del Prete, Giacomina Brunetti, Alberta Zallone, Giorgio Mori, Arcangelo Liso, Graziana Colaianni
Publikováno v:
Blood. 104:3722-3730
The development of multiple myeloma (MM) bone disease is mediated by increased number and activity of osteoclasts (OCs). Using an in vitro osteoclastogenesis model consisting of unstimulated and unfractionated peripheral blood mononuclear cells (PBMC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3051553a5a6371505b709686eb7796c1
https://doi.org/10.1182/blood-2004-02-0474
https://doi.org/10.1182/blood-2004-02-0474
Autor:
Antonia Zonno, Roberto Guariglia, Oreste Villani, Rosa Lerose, Fiorella D'Auria, Giuseppe Pietrantuono, Pellegrino Musto, Maria Carmen Martorelli
Publikováno v:
Leukemia Research. 32:1637-1638
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5498267c8e36626160cfbc8bccd1669
https://doi.org/10.1016/j.leukres.2008.03.013
https://doi.org/10.1016/j.leukres.2008.03.013
Autor:
A. Falcone, Antonia Zonno, Roberto Guariglia, Grazia Sanpaolo, Oreste Villani, Fiorella D'Auria, Pellegrino Musto, Giuseppe Pietrantuono
Publikováno v:
Leukemia Research. 31:S112-S113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6cf8bec07f595193be56d5007c8660e
https://doi.org/10.1016/s0145-2126(07)70204-7
https://doi.org/10.1016/s0145-2126(07)70204-7
Autor:
Pellegrino Musto, Vittorio Simeon, Giovanni D'Arena, Maria Carmen Martorelli, Maria Teresa Petrucci, Anna Levi, Nicola Cascavilla, Antonietta Pia Falcone, Francesco Di Raimondo, Maide Cavalli, Tommaso Caravita, Fortunato Morabito, Massimo Offidani, Nunzio Filardi, Francesco Nobile, Giulia Benevolo, Giuseppe Pietrantuono, Oreste Villani, Roberto Guariglia, Giovanna Mansueto, Rosa Lerose, Antonia Zonno, Valentina Santopietro, Fiorella D'Auria, Teodora Statuto, Katia Todoerti, Sara Bringhen, Francesca Gay, Paola Omedè, Antonino Neri, Mario Boccadoro, Antonio Palumbo
Publikováno v:
Blood. 120:729-729
Abstract 729 Introduction: The prognosis of primary plasma cell leukemia (PPCL) remains poor. The “novel agents” have recently shown promising results in PPCL patients in case reports or small retrospective series. Here we describe the first pros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ced5ceed22a0f3dc2dddd5330f2de040
https://doi.org/10.1182/blood.v120.21.729.729
https://doi.org/10.1182/blood.v120.21.729.729
Autor:
Pellegrino Musto, Fiorella D'Auria, Maria Teresa Petrucci, Anna Levi, Nicola Cascavilla, Antonietta Falcone, Francesco Di Raimondo, Maide Cavalli, Tommaso Caravita, Fortunato Morabito, Massimo Offidani, Nunzio Filardi, Francesco Nobile, Giulia Benevolo, Giuseppe Pietrantuono, Maria Carmen Martorelli, Oreste Villani, Roberto Guariglia, Giovanna Mansueto, Giovanni D'Arena, Rosa Lerose, Antonia Zonno, Emanuela Zifarone, Valentina Santopietro, Katia Todoerti, Sara Bringhen, Francesca Gay, Paola Omedè, Antonino Neri, Mario Boccadoro, Antonio Palumbo
Publikováno v:
Blood. 118:2925-2925
Abstract 2925 Primary plasma cell leukemia (PPCL) is an aggressive variant of multiple myeloma, accounting for 0.5–4% of all newly diagnosed myeloma cases and characterized by a short survival (generally less than 1 year), which is only moderately
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a101dd5efca752b76d1078b01a06bc04
https://doi.org/10.1182/blood.v118.21.2925.2925
https://doi.org/10.1182/blood.v118.21.2925.2925